Navigation Links
First Lady Laura Bush Joins Susan G. Komen for the Cure (R) to Launch Global Promise Fund Assisting Women Worldwide
Date:3/12/2008

Washington Diplomatic Community Engaged to Decrease Growing Global Breast

Cancer Incidence, Mortality Rates

WASHINGTON, March 12 /PRNewswire/ -- First Lady Laura Bush today helped to launch the Susan G. Komen for the Cure (R) Global Promise Fund at a Capitol Hill event to raise awareness of the organization's life-saving work and outline its new strategy of funding culturally sensitive, sustainable education and outreach programs around the world.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070122/NYM084LOGO)

Members of the diplomatic community were present as Mrs. Bush delivered the keynote address and shared her personal perspective on the importance of educating women and their families around the globe. Special guest Dr. Samia Al-Amoudi, a physician from Saudi Arabia who diagnosed her own breast cancer and is now a leading breast cancer advocate, also discussed her work with Susan G. Komen for the Cure in breaking the silence about breast cancer in her home country.

"Work that started in a living room in Dallas 25 years ago is saving the lives of women in Budapest, Dubai, Guadalajara, Jeddah, Rome and other cities around the world," Mrs. Bush said. "This is the story of Susan G. Komen for the Cure."

"Without a cure, an estimated 25 million women around the world will be diagnosed with breast cancer over the next 25 years -- and 10 million could die from the disease," said Komen for the Cure President and CEO Hala Moddelmog. "Our new Global Promise Fund is specifically designed to allow donors -- corporate and individual -- to help fund targeted projects in specific countries around the world to address the growing global burden of breast cancer."

For more than 25 years, Mrs. Bush has actively participated in the breast cancer awareness movement, including serving as Honorary Co-Chair of Susan G. Komen for the Cure's landmark Global Advocate Summit in Budapest, Hungary last year. Mrs. Bush also led an historic tour of the Middle East last fall to Riyadh, Saudi Arabia, where she launched the U.S.-Middle East Partnership for Cancer Awareness and Research in collaboration with Susan G. Komen for the Cure, King Fahd Medical City, the Saudi Cancer Society, The U.S. Department of State and The University of Texas M.D. Anderson Cancer Center.

"I'm proud to be part of this historic campaign for good health for women worldwide," Mrs. Bush added. "I urge all the members of the diplomatic community who have joined us today to make breast cancer education and outreach priorities in your own countries. You can help break the silence."

Susan G. Komen for the Cure's Global Promise Fund will focus on the following priorities:

-- Increasing breast health awareness and access to detection and

treatment of breast cancer;

-- Building detection and treatment infrastructure;

-- Recruiting and staffing specialized fields like oncology and radiology;

-- Serving breast cancer survivors and their families;

-- Recruiting and training of lay ambassadors to promote breast cancer

awareness and treatment options in underserved areas.

The launch of this Promise Fund will strengthen the organization's growing presence throughout the world. Last year, at the Global Advocate Summit, Komen launched The Global Initiative for Breast Cancer Awareness, a 10-country pilot program, to assist countries in decreasing breast cancer mortality rates. Countries participating in this initiative include Brazil, Costa Rica, Ghana, India, Jordan, Mexico, Romania, Saudi Arabia, Ukraine and the United Arab Emirates.

With $1 billion invested to fight breast cancer in the past 25 years, Komen pledged last year to invest another $2 billion in research and community-based programs within the next decade to dramatically decrease breast cancer incidence and deaths resulting from the disease.

Mrs. Bush closed her remarks to the diplomatic community by referring to Komen's worldwide efforts as "a force to be reckoned with."

About Susan G. Komen for the Cure

Nancy G. Brinker promised her dying sister, Susan G. Komen, she would do everything in her power to end breast cancer forever. In 1982, that promise became Susan G. Komen for the Cure and launched the global breast cancer movement. Today, Komen for the Cure is the world's largest grassroots network of breast cancer survivors and activists fighting to save lives, empower people, ensure quality care for all and energize science to find the cures. Thanks to events like the Komen Race for the Cure, we have invested nearly $1 billion to fulfill our promise, becoming the largest source of nonprofit funds dedicated to the fight against breast cancer in the world. For more information about Susan G. Komen for the Cure, breast health or breast cancer, visit http://www.komen.org or call 1-877 GO KOMEN.


'/>"/>
SOURCE Susan G. Komen for the Cure
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Providence Service Corporation Announces Fourth Quarter 2007 Revenue and Earnings Above Forecast; Issues First Quarter 2008 Guidance
2. First Over-The-Counter Store Brand Omeprazole Offering in U.S. Market Creates New Option for Frequent Heartburn Sufferers
3. First early-detection blood test for Parkinsons shows promise
4. Which came first, social dominance or big brains? Wasps may tell
5. Skills Application and Productivity Rank as the Most Effective Training Measures for First-Year Pharmaceutical Reps
6. Physicians and Nurses Against Tobacco (PANAT) Petition Pope Benedict XVI to Condemn Tobacco Industry, and Tobacco Use, and Declare Vatican First Tobacco- Free Country
7. VoIP-PAL.com, Inc. (Pink Sheets: VPLM.PK - News) UPDATE: Announces First Award Recipient of TalkfortheCure(TM) Dollars
8. First-Ever National Board Certification(R) for Americas Health Educators Arrives
9. First-Time Shoulder Dislocations Helped by Surgery
10. Who is Your RD? To Mark First Registered Dietitian Day, American Dietetic Association Urges Everyone to Start Having an Annual Nutrition Checkup
11. Controversial shoulder surgery for first-time dislocation proven effective long-term
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... Lewisville, TX (PRWEB) , ... August 16, 2017 , ... ... in the United States, named Dr. Douglas J. Harrison, as the new Medical Director ... will be the new facility Medical Director of our Sienna Plantation location,” said Dr. ...
(Date:8/16/2017)... ... , ... “God Will Break Every Chain”: an inspirational story for those shackled by the chains ... author, Evangelist Joann Shivers, a writer and a woman of great faith and wisdom. ... early age. She was born and raised in Vero Beach, Florida and has dedicated ...
(Date:8/15/2017)... ... August 15, 2017 , ... The first study to ... multiple myeloma has been completed, with the team’s findings now published online ahead of ... , Director of the Blood and Marrow Transplant Program at Roswell Park Cancer Institute, ...
(Date:8/15/2017)... ... August 15, 2017 , ... Progressive Dental, a leading ... on the 2017 Fast 50 list of Fastest Growing Companies in Tampa Bay. The ... area who has shown three consecutive years of growth. For this year’s award, Progressive ...
(Date:8/15/2017)... ... August 15, 2017 , ... Dr. Timothy Davis ... periodontal disease . This information can be used to develop patient-specific treatment ... The two salivary diagnostic tests, named MyPerioPath® and MyPerioID® are offered by OralDNA® ...
Breaking Medicine News(10 mins):
(Date:7/28/2017)... Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), today ... June 30, 2017, and updated its financial outlook for ... For the fiscal third quarter, Hill-Rom reported earnings of ... share in the prior-year period. These results reflect after-tax ... share primarily related to the non-cash write-down of assets ...
(Date:7/27/2017)... Pa., July 27, 2017  West Pharmaceutical Services, Inc. ... results for the second-quarter 2017 and updated financial guidance ... Second-Quarter 2017 Highlights Reported net ... over the prior-year quarter. Net sales at constant currency ... reported-diluted EPS was $0.51, compared to $0.60 in the ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals Company, ... our clinical trial evaluating Altemia TM , an oral ... and Sickle Cell Disease (SCD). The SCOT Trial, is ... efficacy and safety of Altemia TM in pediatric ... under US IND 125274. ...
Breaking Medicine Technology: